INSTANT STREAMING COURSE
Share:

FDA Compliant QC and QA Practices – Creating a Perfect, Audit-Ready QMS

This course equips pharmaceutical quality professionals to strengthen QC and QA coordination, reduce inspection exposure, and build a QMS that consistently supports GMP compliance, audit readiness, and product quality expectations across manufacturing operations. This Course is designed for professionals responsible for pharmaceutical manufacturing quality systems, compliance oversight, documentation, and audit preparation.

REGISTER FOR THE COURSE

US $190 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $190 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
     Joy Mcelroy
  • Duration
    90 Minutes
  • Course ID
    TF2557
  • Ask the Expert
    Included
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

About the Course

Pharmaceutical manufacturers rely on Quality Control and Quality Assurance functions to ensure products meet safety, efficacy, identity, and intended-use expectations. These responsibilities extend beyond laboratory testing and documentation review, requiring clear operational boundaries, coordinated oversight, and consistent GMP application throughout manufacturing activities. Regulatory agencies expect both functions to operate within a structured Quality Management System that supports reliable decision-making, procedural control, and product quality. Weaknesses in these areas can increase inspection findings, disrupt operations, and raise concerns regarding compliance practices.


Effective quality systems require alignment between procedures, training, auditing practices, and day-to-day execution. This program clarifies FDA expectations for QC and QA operations, identifies common compliance gaps associated with inspection observations, and explains the elements required for an audit-ready QMS. Attention is also given to applying GMP principles within routine quality activities so organizations can maintain consistent oversight and support sustainable manufacturing performance.

  • Strengthen QC and QA Accountability:

    Clear separation and coordination of Quality Control and Quality Assurance responsibilities reduces operational confusion during inspections and internal reviews. Participants gain practical understanding of FDA expectations, batch record oversight, procedural consistency, and GMP application within daily quality activities. These capabilities support more reliable manufacturing decisions and reduce exposure to recurring compliance observations.

  • Build a QMS Ready for Regulatory Scrutiny:

    A well-structured Quality Management System demonstrates organizational control over product quality, procedural compliance, and audit preparedness. This course explains the operational components needed to maintain inspection readiness, support consistent documentation practices, and reinforce communication between QC and QA functions. Facilities facing increasing regulatory attention benefit from stronger system accountability and clearer quality responsibilities.

Key Areas Covered

  • FDA expectations for Quality Control and Quality Assurance operations
  • Functional differences and operational coordination between QC and QA units
  • Common compliance deficiencies associated with FDA 483 observations
  • Core requirements for establishing and maintaining an effective Quality Management System
  • Application of GMP principles within Quality Control and Quality Assurance activities
  • Procedures and operational practices supporting audit-ready quality systems
  • Responsibilities of Quality Control in ensuring product identity, safety, and defect prevention
  • Methods for maintaining procedural consistency and regulatory readiness across quality operations

Who Must Attend

  • Quality Control Departments
  • Quality Assurance Departments
  • Research and Development Teams
  • Regulatory Affairs Departments
  • Management and Supervisory Team
  • Validation Departments

Quality training, expert insights, and answers that matter. Know your Expert

JOY MCELROY

Joy McElroy has more than 25 years of pharmaceutical and biotech industry experience spanning Quality Control, Quality Assurance, GMP compliance auditing, equipment qualification, cleaning validation, and technical writing. Her background includes laboratory supervision, batch record review, GMP training, and validation protocol execution for companies including Wyeth Lederle, Merck, Catalent, and Novartis. She also provides GMP, audit preparation, SOP writing, and compliance training through her consultancy, McElroy Training and Consultancy, LLC.

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

How do FDA investigators determine whether a Quality Management System is genuinely effective rather than simply well documented?

An effective Quality Management System is demonstrated through consistent execution, not by the volume of controlled documents. Investigators compare written procedures with actual practices to determine whether quality decisions are routinely implemented across manufacturing, laboratories, and supporting functions.


Inspection attention often increases when quality records show recurring deviations, repeated corrective actions, or unresolved quality trends despite detailed procedures. Those patterns suggest that documented processes are not producing the intended operational outcomes. Interviews, record reviews, and observations are frequently used together to evaluate whether personnel consistently follow established quality practices.


Organizations sometimes invest considerable effort in maintaining documentation while giving less attention to measuring whether quality activities remain effective over time. A procedure that exists but fails to prevent recurring problems provides limited confidence during regulatory review.


A well controlled Quality Management System is supported by objective evidence showing that investigations lead to meaningful improvements, quality metrics drive informed decisions, and management verifies the sustained effectiveness of corrective actions. Those indicators demonstrate operational control beyond procedural compliance.

What evidence demonstrates that QC and QA functions maintain appropriate independence while supporting the same quality objectives?

Appropriate independence is demonstrated when Quality Control and Quality Assurance perform distinct responsibilities while relying on shared quality principles and documented decision making. Investigators look for evidence that technical reviews, batch disposition, investigations, and quality oversight remain objective even when production schedules create operational pressure.


Inspection concerns often arise when one function routinely accepts responsibilities that properly belong to the other or when critical quality decisions are influenced by manufacturing priorities rather than documented evidence. Blurred accountability can make approval decisions difficult to justify during regulatory review.


Supporting records should consistently identify who evaluated the available evidence, who made the final quality decision, and how differing technical opinions were resolved. Clear documentation of those responsibilities provides greater confidence than organizational charts or written job descriptions alone.


A defensible quality system demonstrates collaboration without compromising independent oversight. Consistent decision making, transparent escalation processes, and clearly documented authority help show that quality responsibilities remain appropriately separated while supporting the same product quality objectives.

When should recurring quality issues be treated as evidence of broader system weaknesses instead of isolated operational events?

Recurring quality issues should prompt evaluation of the overall Quality Management System when similar events continue despite previous investigations or corrective actions. Repeated observations often indicate that underlying processes, governance, or oversight activities require broader assessment than the individual event alone.


Investigators frequently review historical deviations, complaint trends, CAPAs, audit findings, laboratory events, and production records together to determine whether recurring problems share common causes. Examining each issue independently may overlook patterns that become evident only through trend analysis across multiple quality systems.


Inspection discussions become more difficult when repeated events are consistently classified as unrelated without documented technical justification. Decisions to limit the scope of review should be supported by objective evidence explaining why broader systemic evaluation was unnecessary.


Strong quality oversight includes periodic assessment of recurring issues across departments, products, and manufacturing activities. That approach provides better assurance that corrective actions address underlying system performance rather than repeatedly resolving the same operational symptoms.

What makes quality decisions difficult to defend during an FDA inspection even when procedures appear compliant?

Quality decisions become difficult to defend when documentation records the final action but does not explain the reasoning that supported it. Investigators frequently evaluate whether available evidence, technical judgment, and documented rationale consistently support batch disposition, investigations, deviations, change controls, and corrective actions.


Inspection confidence decreases when related records contain conflicting conclusions or when significant quality decisions depend primarily on verbal explanations from personnel. Reviewers expect the documented record to demonstrate how available information was evaluated and why the selected course of action was appropriate.


Completed procedures alone provide limited assurance if important decisions cannot be traced to objective evidence. Missing rationale often results in additional inspection questions because reviewers cannot independently assess the basis for the organization's conclusions.


Well supported quality decisions present a consistent technical narrative across quality records, allowing an independent reviewer to understand the evidence, follow the decision process, and reach the same conclusion without relying on institutional knowledge or undocumented assumptions.

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can watch the course, access materials, and manage your learning.

3. Access course materials
The presentation handout and other materials can be downloaded inside the Course Player. You could use Discussion feature there to ask your questions.

4. Watch The Streaming and Complete your Course
The course playback will be available on the same course page. You could pause and continue or you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

The challenge with training is rarely signing up. It’s what happens afterward, when access, materials, & certification aren’t accessible from one place.
With TalkFDA Courses, Everything you need Live in One Place.
Simple. Organized. Professional.
Go ahead and Take the Course with confidence.

Our students love us ❤️

“Presenter kept the content focused on actual GMP and inspection concerns instead of theory.”


Specialist, Quality Operations

“Discussion around audit readiness and QMS expectations was practical and easy to apply internally.”


Supervisory Team

“Good breakdown of QC and QA responsibilities. It clarified where common compliance issues usually begin.”


Manager, Quality Assurance

People who took this Course, also viewed